IL-18BP is a secreted immune checkpoint and barrier to IL-18 immunotherapy

Nature, Published online: 24 June 2020; doi:10.1038/s41586-020-2422-6

An engineered version of IL-18 that is resistant to binding by the soluble decoy receptor IL-18BP shows strong anti-tumour activity in mouse models of cancer.

Comments

Popular posts from this blog

Photo Of The Day By Valerie Millett